Cardiac care service use, satisfaction affected by socioeconomic status

March 2004
PharmacoEconomics & Outcomes News;3/27/2004, Issue 449, p8
Discusses research being done on the socioeconomic status, service patterns and perceptions of care among survivors of acute myocardial infarction in Canada. Reference to a study by D. A. Alter et al published in the March 3, 2004 issue of the "Journal of the American Medical Association"; Findings of the study.


Related Articles

  • Increasing socioeconomic inequalities in first acute myocardial infarction in Scotland, 1990-92 and 2000-02. Davies, Carolyn A.; Dundas, Ruth; Leyland, Alastair H. // BMC Public Health;2009, Vol. 9 Issue 1, p1 

    Background: Despite substantial declines, Ischaemic Heart Disease (IHD) remains the largest cause of death in Scotland and mortality rates are among the worst in Europe. There is evidence of strong, persisting regional and socioeconomic inequalities in IHD mortality, with the majority of such...

  • New Genes, New Insights for Heart Disease Therapies. Kingsman, Sharon // BioWorld International;2/18/2009, Vol. 14 Issue 7, p1 

    The article reports that the identification of genetic variants associated with a higher risk of coronary artery disease will provide new insights into its causes, together with the possibility of developing novel ways of preventing it, predicting it and treating it, according to studies...

  • Always look on the bright side…. McCrory, P. // British Journal of Sports Medicine;Feb2007, Vol. 41 Issue 2, p63 

    The author reflects on the increasing number cardiovascular mortality in sports. According to the author, several studies have demonstrated increased cardiovascular mortality with the outcome of local and national football teams. He pointed that mostly is male mortality from myocardial...

  • Review: Diabetes is not a coronary disease equivalent. Farkouh, Michael E.; Idris, I. // ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p4 

    The article reports that patients with diabetes and no history of myocardial infarction (MI) have a lower risk for coronary artery disease (CAD) events than patients with previous MI and no diabetes. Included studies compared risk for CAD events in patients with diabetes and no MI and patients...

  • COURTESY CALLS. Gamon, Roger; Harte, Declan; Barnes, Neil; Higham, Philip; Lecky, Fiona // Emergency Nurse;Jun2004, Vol. 12 Issue 3, p20 

    Describes how courtesy calls to myocardial infarction medical teams can reduce door-to-needle times, based on a study conducted in Great Britain from 2000 to 2001. Methodology; Initial results; Final results; Study limitations.

  • Pneumococcal jab cuts MI risk.  // GP: General Practitioner;10/10/2008, p10 

    The article reports on the findings of a study conducted by researchers in Canada concerning the use of pneumococcal vaccination. The study reveals that pneumococcal vaccination reduces heart attack rates. It notes that patients admitted for myocardial infarction (MI) were 47 percent less likely...

  • News in brief.  // Reactions Weekly;6/4/2005, Issue 1054, p3 

    Discusses research being done on angiotensin receptor blockers and myocardial infarction. Reference to a study by J. McMurray published in the May 28, 2005 issue of the "British Medical Journal"; Findings of the study.

  • DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93 

    The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...

  • POEMs & Tips. Slaw; Shaughnessy, Allen F.; Ebell, Mark; Walling, Anne D.; Miller, Karl E.; Wellbery, Caroline // American Family Physician;3/1/2006, Vol. 73 Issue 5, p892 

    Provides an overview of several medical research. "High-Risk Patients With Acute Coronary Syndromes Treated With Low-Molecular- Weight or Unfractionated Heparin. Outcomes at 6 Months and 1 Year in the SYNERGY Trial," by K. W. Mahaffey, et al; "High-Dose Atorvastatin vs Usual-Dose Simvastatin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics